TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TCRX

Tscan Therapeutics Inc

Healthcare · Biotechnology

0.3335$ +0.8% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Tscan Therapeutics Inc (TCRX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/11/2026.

Next report 08/11/2026
Last report 08/12/2026
Earnings surprise by quarter (%)
Q3 23 · 45.5 % 23 Q4 23 · 27.6 % 23 Q1 24 · -33.3 % 24 Q2 24 · 0.0 % 24 Q3 24 · 13.8 % 24 Q4 24 · -3.5 % 24 Q1 25 · 7.1 % 25 Q2 25 · 12.5 % 25 Q3 25 · 15.2 % 25 Q4 25 · 32.6 % 25 Q1 26 · -37.5 % 26 Q2 26 · 20.7 % 26

EPS estimate beaten

Full history 13 of 22 quarters (59%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/11/2026 TScan Therapeutics, Inc. (TCRX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗
  • 09/02/2026 TScan Therapeutics, Inc. (TCRX): Cost Associated with Exit or Disposal Activities; Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/18/2026 TScan Therapeutics, Inc. (TCRX): Termination of a Material Definitive Agreement · sec.gov Open ↗
  • 08/12/2026 TScan Therapeutics, Inc. (TCRX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?